Search

Search Results

Found 173 results for 'Pass Guaranteed Quiz 2024 JN0-683: Fantastic Data Center, Professional (JNCIP-DC) Reliable Test Blueprint 📻 Open 「 www.pdfvce.com 」 enter { JN0-683 } and obtain a free download 🐹JN0-683 Valid Study Materials'

  • Publication

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study

Angela Schulz, MD PhD , Nicola Specchio, MD PhD, Emily de los Reyes, MD, Paul Gissen, MD PhD, Miriam Nickel, MD, Marina Trivisano, MD PhD, Shawn C Aylward, MD, Anupam Chakrapani, MD, Christoph Schwering, MD, Eva Wibbeler, MD, Lena Marie Westermann, MD, Douglas J Ballon, PhD, Jonathan P Dyke, PhD DABMP, Anu Cherukuri, PhD, Shailesh Bondade, MD, Peter Slasor, ScD, Jessica Cohen Pfeffer, MD

  • Publication

Lifetime Impact Study for Achondroplasia (LISA): Findings from an observational and multinational study focused on health-related quality of life in individuals with achondroplasia in Latin America

Juan Llerena Jr, Pablo Rosselli, Amanda Aragao, Cristina Valenzuela, Debora Bertola, Yaneth Mendez, Mariana del Pino, Nicolette Calvacanti, Paula Thomazinho, Jeanne M. Pimenta, Shelda Cohen, Tom Butt, Jose C. Thomaz Jr, Renee Shediac , Richard Rowell, Tatiana S.P.C. Magalhaes, Chong Kim, Virginia Fano

  • Publication

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

Angela Schulz, M.D., Temitayo Ajayi, M.D., Nicola Specchio, M.D., Ph.D., Emily de Los Reyes, M.D., Paul Gissen, M.B., Ch.B., Ph.D., Douglas Ballon, Ph.D., Jonathan P. Dyke, Ph.D., Heather Cahan, M.D., Peter Slasor, Sc.D., David Jacoby, M.D., Ph.D., and Alfried Kohlschütter, M.D., for the CLN2 Study Group

  • Page

BioMarin Leadership Team

Meet the team leading BioMarin into the future Meet the team leading BioMarin into the future…